It is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled with glimipride or metformin Hcl alone, or for those patients who have initially responded to glimipride or metformin Hcl alone and required additional glycemic control.